Zobrazeno 1 - 10
of 123
pro vyhledávání: '"Mihaela MUNTEANU"'
Autor:
Mihaela MUNTEANU, Mihail POPOVICI, Victoria IVANOV, Lucia CIOBANU, Ion POPOVICI, Ion MORARU, Valeriu COBEȚ
Publikováno v:
Buletinul Academiei de Ştiinţe a Moldovei: Ştiinţe Medicale, Vol 78, Iss 1, Pp 106-114 (2024)
Цель. Изучение функциональных особенностей изолированного сердца при постинфарктном ремоделировании миокарда с целью выявления компе
Externí odkaz:
https://doaj.org/article/e194a53231534700b885b09e2da5e821
Publikováno v:
Buletinul Academiei de Ştiinţe a Moldovei: Ştiinţe Medicale, Vol 78, Iss 1, Pp 156-165 (2024)
O mare majoritate (până la 70%) dintre pacienții supuși angiografiei coronariene din cauza anginei și a semnelor de ischemie miocardică nu au artere coronare obstructive. Studiile efectuate în ultimele decenii au evidențiat că disfuncția co
Externí odkaz:
https://doaj.org/article/b1d3696acbfa49e6ba44abf83594e078
Autor:
Mihaela MUNTEANU
Publikováno v:
Buletinul Academiei de Ştiinţe a Moldovei: Ştiinţe Medicale, Vol 78, Iss 1, Pp 7-16 (2024)
Scop. Evaluarea markerilor clasici și noi ai dereglării microcirculației coronariene (DMC) care au valoare predictivă asupra riscului evenimentelor cardiovasculare majore (MACE) la pacienții cu STEMI și NSTEMI. Material și metode. Cercetarea a
Externí odkaz:
https://doaj.org/article/b7fe50d191744368908a6c53ec72b8eb
Publikováno v:
Buletinul Academiei de Ştiinţe a Moldovei: Ştiinţe Medicale, Vol 78, Iss 1, Pp 42-48 (2024)
Introducere. Deși în ultimele decenii s-au realizat progrese notabile în managementul pacienților cu infarct miocardic fără supradenivelarea segmentului ST (NSTEMI), rata mortalității intraspitalicești rămâne ridicată. Aceasta depinde de
Externí odkaz:
https://doaj.org/article/6674a3d1e7084b56817ab70d5b3f9f8c
Autor:
Olga DICUSAR, Carolina DUMANSCHI, Victoria IVANOV, Lucia CIOBANU, Ion POPOVICI, Mihaela MUNTEANU, Ion MORARU, Tatiana CARAGEA, Victoria TOFAN, Mihail POPOVICI
Publikováno v:
Buletinul Academiei de Ştiinţe a Moldovei: Ştiinţe Medicale, Vol 78, Iss 1, Pp 57-68 (2024)
Scop: Aprecierea ratei infarctului miocardic fără elevarea segmentului ST cu artere coronare non-obstructive (NSTE- MINOCA) și analiza comparativă a datelor clinice și de management cu infarctul miocardic fără elevarea segmentului ST cu artere
Externí odkaz:
https://doaj.org/article/4ab87a8cf2844a9e8c49364c49e23ad0
Autor:
Irfan Cicin, Elizabeth R. Plimack, Howard Gurney, Raya Leibowitz, Boris Y. Alekseev, Francis X. Parnis, Avivit Peer, Andrea Necchi, Joaquim Bellmunt, Hiroyuki Nishiyama, Jason Clark, Mihaela Munteanu, Ritesh Kataria, Calvin Jia, Thomas Powles, Cora N. Sternberg
Publikováno v:
BMC Cancer, Vol 23, Iss S1, Pp 1-11 (2024)
Abstract Background Indoleamine 2,3-dioxygenase 1 (IDO1) levels correlate with poor outcomes in urothelial carcinoma (UC). IDO1 and programmed death-ligand 1 (PD-L1) are often co-expressed. Epacadostat is a potent and highly selective inhibitor of ID
Externí odkaz:
https://doaj.org/article/263d9199baf8485699909ce6591e41d9
Autor:
Primo N. Lara, Luis Villanueva, Carolina Ibanez, Mustafa Erman, Jae Lyun Lee, Daniel Heinrich, Oleg Nikolaevich Lipatov, Craig Gedye, Erhan Gokmen, Alejandro Acevedo, Andrey Semenov, Se Hoon Park, Rustem Airatovich Gafanov, Fatih Kose, Mark Jones, Xiaoqi Du, Mihaela Munteanu, Rodolfo Perini, Toni K. Choueiri, Robert J. Motzer
Publikováno v:
BMC Cancer, Vol 23, Iss S1, Pp 1-12 (2024)
Abstract Background Immunotherapy-based combinations have emerged as standard therapies for patients with metastatic renal cell carcinoma (mRCC). Pembrolizumab, a PD-1 inhibitor, combined with epacadostat, an indoleamine 2,3-deoxygenase 1 selective i
Externí odkaz:
https://doaj.org/article/f27c30f1bd8e406580492b76ee1bb216
Autor:
Andrea Necchi, Michiel S. Van der Heijden, Dmytro Trukhin, Avivit Peer, Howard Gurney, Boris Y. Alekseev, Francis X. Parnis, Raya Leibowitz, Maria De Santis, Petros Grivas, Jason Clark, Mihaela Munteanu, Ritesh Kataria, Calvin Jia, Arjun V. Balar, Ronald de Wit
Publikováno v:
BMC Cancer, Vol 23, Iss S1, Pp 1-11 (2024)
Abstract Background Indoleamine 2,3- dioxygenase 1 (IDO1) is an immunosuppressive enzyme that has been correlated with shorter disease-specific survival in patients with urothelial carcinoma (UC). IDO1 may counteract the antitumor effects of immune c
Externí odkaz:
https://doaj.org/article/37a2f0fcea5140a684940d22b18e5a1a
Autor:
Byoung Chul Cho, Irene Braña, Beatriz Cirauqui, Sercan Aksoy, Felix Couture, Ruey-Long Hong, Wilson H. Miller, Manuel Chaves-Conde, Margarida Teixeira, Lance Leopold, Mihaela Munteanu, Joy Yang Ge, Ramona F. Swaby, Brett G. M. Hughes
Publikováno v:
BMC Cancer, Vol 23, Iss S1, Pp 1-12 (2024)
Abstract Background Advanced head and neck squamous cell carcinoma (HNSCC) has a poor prognosis, and new treatment options are needed. Combining immunotherapies with differing mechanisms of action may enhance clinical benefits compared with single-ag
Externí odkaz:
https://doaj.org/article/24bfd93adc7946a58a1c047c4d340cb7
Autor:
Takaaki Tokito, Oleksii Kolesnik, Jens Sørensen, Mehmet Artac, Martín Lázaro Quintela, Jong-Seok Lee, Maen Hussein, Miklos Pless, Luis Paz-Ares, Lance Leopold, Jeannie Daniel, Mihaela Munteanu, Ayman Samkari, Lu Xu, Charles Butts
Publikováno v:
BMC Cancer, Vol 23, Iss S1, Pp 1-11 (2024)
Abstract Background Pembrolizumab is a first-line therapy for certain patients with advanced/metastatic non-small cell lung cancer (NSCLC). Combining pembrolizumab with other immunotherapies may enhance tumor cell killing and clinical outcomes. Epaca
Externí odkaz:
https://doaj.org/article/778d9a0bf7f040a3adf76b4a236aef6f